The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after successful clinical trials show the drug nearly eliminated the infection spread. (NBC News), (AP) Management of HIV/AIDS link embed save